Investing.com - Maia Biotechnology (NYSE: MAIA) reported first quarter EPS of $-0.40, $0.03 better than the analyst estimate of $-0.43. Revenue for the quarter came in at $0.00 versus the consensus estimate of $0.00.
Maia Biotechnology's stock price closed at $2.84. It is down -36.04% in the last 3 months and up 0.00% in the last 12 months.
Maia Biotechnology saw positive EPS revisions and negative EPS revisions in the last 90 days. See Maia Biotechnology's stock price’s past reactions to earnings here.
According to InvestingPro, Maia Biotechnology's Financial Health score is "weak performance".
Check out Maia Biotechnology's recent earnings performance, and Maia Biotechnology's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar